Advanced MedTech Holdings (AMTH), Southeast Asia's largest medical device business headquartered in Singapore, has announced that it has co-led a $10 million Series B funding in SonoMotion, a US-based medical device startup, together with its existing investors MedVenture Partners, Inc and BioVentures Investors, to support its development of non-invasive solutions for kidney stones.

The funds raised will fund a pivotal study of Break Wave^(TM), SonoMotion's ultrasound solution that fragments kidney stones non-invasively. SonoMotion also plans to launch Stone Clear^(TM), a non-invasive ultrasound-based tool to reposition kidney stones within the kidney and ureter, in 2020.

Both technologies aim to bring greater convenience and comfort for patients and physicians, offering new alternatives in stone management that potentially remove the need for anesthesia or ionizing radiation.